R C Gregoire
Overview
Explore the profile of R C Gregoire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Apte S, Majumdar S, Agborsangaya C, Rueda-Clausen C, Klarenbach S, Sharma A, et al.
Can J Surg
. 2025 Jan;
57(4suppl1):S85-S139.
PMID: 39818541
No abstract available.
2.
Nenshi R, Kennedy E, Saskin R, Vassiliou M, Fayez R, Krajewski S, et al.
Can J Surg
. 2022 Apr;
52(Suppl):S1-S48.
PMID: 35488397
No abstract available.
3.
Bodie G, Hagen J, Almamar A, Majumdar S, Wang X, Tuepah R, et al.
Can J Surg
. 2022 Apr;
55(4 Suppl 1):S63-S135.
PMID: 35488395
No abstract available.
4.
Hallet J, Milot H, Drolet S, Desrosiers E, Gregoire R, Bouchard A
Tech Coloproctol
. 2014 Mar;
18(6):579-90.
PMID: 24615720
Turnbull and Cutait described abdominoperineal pull-through followed by delayed coloanal anastomosis (DCA) in 1961. DCA could reduce anastomotic leaks, pelvic morbidity and use of stomas. Strong evidence about its clinical...
5.
McLeod R, Geerts W, Sniderman K, Greenwood C, Gregoire R, Taylor B, et al.
Ann Surg
. 2001 Feb;
233(3):438-44.
PMID: 11224634
Objective: To compare the effectiveness and safety of low-dose unfractionated heparin and a low-molecular-weight heparin as prophylaxis against venous thromboembolism after colorectal surgery. Methods: In a multicenter, double-blind trial, patients...
6.
Kashtan H, Gregoire R, Hay K, Stern H
Cancer Invest
. 1993 Jan;
11(2):113-7.
PMID: 8462011
Rectal mucosal (epithelial) proliferation labeling indices (LI) have been widely used as a risk marker for colorectal cancer and as an intermediate end-point in chemoprevention studies. The purpose of this...
7.
Gregoire R, Kashtan H, Stern H, Yeung K, Stadler J, Neil G, et al.
Surg Oncol
. 1992 Feb;
1(1):43-7.
PMID: 1341234
Epidemiological and animal studies suggest that faecal pH may be a risk factor for colorectal cancer with low faecal pH associated with a lower incidence of the disease. The aim...
8.
Stern H, Gregoire R, Kashtan H, Stadler J, Bruce R
Surgery
. 1990 Sep;
108(3):528-33.
PMID: 2168586
There is conflicting evidence regarding the benefit of calcium in prevention of colon cancer. Patients who have undergone ileorectal operations for familial polyposis can be useful to study hypotheses on...
9.
Kashtan H, Gregoire R, Bruce W, Hay K, Stern H
J Natl Cancer Inst
. 1990 Jun;
82(11):950-2.
PMID: 2342129
High fecal pH level has been suggested as a risk factor for colorectal cancer. We previously demonstrated that, although sodium sulfate did not affect the proliferation rate of colonic mucosa,...
10.
Gregoire R, Stern H, Yeung K, Stadler J, Langley S, Furrer R, et al.
Gut
. 1989 Mar;
30(3):376-82.
PMID: 2707638
Recent findings suggest that supplemental calcium could lower the abnormally high proliferation rate found in the colonic mucosa of subjects at high risk for colon cancer. In this double blind...